Seize the opportunity to share your suggestions on how the FDA can improve its currently opaque “transparency policy.“ A second public meeting will be held November 3, 2009, from 9 a.m. to 3 p.m. in the National Transportation Safety Board Conference Center at 429 L’Enfant Plaza, SW, Washington, DC (https://secure3.convio.net/aahf/site/Advocacy?cmd=display&page=UserAction&id=431). The three discussion groups are:
Thank you to our 801 advocates who used AAHF’s Action Center to submit comments in response to Docket Number FDA-200-N-0247, letting the Food and Drug Administration’s Transparency Task Force know that you support increased transparency at the FDA. On August 6, AAHF proudly hand-delivered 801 letters to the FDA’s Division of Docket Management. These comments […]
From our friends at Consumers for Dental Choice comes news that the Food & Drug Administration, Associate Commissioner Norris Alderson has declared that mercury amalgams are “…not for MY grandchildren.”